Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

about

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

Item

http://www.wikidata.org/entity/Q55229762

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@en

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@nl

type

Item

label

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@en

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@nl

prefLabel

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@en

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@nl

P1476

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

@en

P2093

Alexandre Alanio

http://www.w3.org/2001/XMLSchema#string

Elvis Temfack

http://www.w3.org/2001/XMLSchema#string

Timothée Boyer Chammard

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast

Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy

A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi

Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

Major role for amphotericin B-flucytosine combination in severe cryptococcosis.

Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

P304

e180050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1590/0074-02760180050

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Lortholary

P5008

ScienceSource

P577

2018-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29742199

http://www.w3.org/2001/XMLSchema#string

P921

cryptococcosis

P932

5942877

http://www.w3.org/2001/XMLSchema#string